破産更生債権等、研究開発費、当期経常利益
- 【期間】
| 年度 | 破産更生債権等 | 研究開発費 | 当期経常利益 |
|---|
| 2009/02 | 0.46百万 | | - | | 89.2億 | |
| 2010/02 | 0.91百万 | +98.3% | - | | -38.8億 | 赤転 |
| 2011/02 | 55,000 | -94% | - | | 11.9億 | 黒転 |
| 2012/02 | 55,000 | ±0% | - | | 40.3億 | +237.1% |
| 2013/02 | - | | 18.9億 | | 22.5億 | -44% |
| 2014/02 | - | | 19.5億 | +2.7% | 32.2億 | +42.8% |
| 2015/02 | - | | 19.5億 | +0.1% | 61.5億 | +91.1% |
| 2016/02 | - | | 20.1億 | +3% | 52.1億 | -15.4% |
| 2017/02 | - | | 20.3億 | +1.3% | 35.8億 | -31.2% |
| 2018/02 | - | | 19.9億 | -1.9% | 70.2億 | +95.8% |
| 2018/12 | - | | 14.7億 | -26.3% | 95.7億 | +36.4% |
| 2019/12 | - | | 16.8億 | +14.3% | 61.6億 | -35.6% |
| 2020/12 | - | | 14.7億 | -12.5% | 27.7億 | -55% |
| 2021/12 | - | | 16.5億 | +12.2% | 78億 | +181.1% |
| 2022/12 | - | | 19.7億 | +19.2% | 142億 | +82.2% |
| 2023/12 | - | | 18.5億 | -5.9% | 110億 | -22.8% |
